Valneva SE (VALN) Income towards Parent Company (2021 - 2026)

Valneva SE's (VALN) quarterly Income towards Parent Company came in at -$27.7 million in Q1 2026, down 342.51% year-on-year from $11.4 million in Q1 2025, and up 52.41% quarter-over-quarter from -$58.3 million in Q4 2025.

Valneva SE (VALN) Income towards Parent Company (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Income towards Parent Company across 6 years of filings, most recently posting -$27.7 million for Q1 2026.

  • Income towards Parent Company for Q1 2026 came in at -$27.7 million, down 342.51% year-over-year; the trailing twelve-month figure through Mar 2026 was -$141.7 million (down 116.52% YoY), and the FY2025 annual result was -$134.1 million, down 1041.56% from the prior year.
  • Income towards Parent Company came in at -$27.7 million for Q1 2026 at Valneva SE, up from -$58.3 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $74.1 million in Q1 2024 to a low of -$151.4 million in Q2 2022.
  • The 5-year median for Income towards Parent Company is -$23.2 million (2024), against an average of -$22.7 million.
  • Across the five-year window, Income towards Parent Company soared 516.53% in 2024 and sank 342.51% in 2026, its largest moves.
  • Valneva SE's Income towards Parent Company stood at -$57.5 million in 2022, then surged by 53.39% to -$26.8 million in 2023, then advanced by 16.72% to -$22.3 million in 2024, then slumped by 161.21% to -$58.3 million in 2025, then jumped by 52.41% to -$27.7 million in 2026.
  • The last three Income towards Parent Company figures came in at -$27.7 million (Q1 2026), -$58.3 million (Q4 2025), and -$43.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -27.74 Mn
Dec 31, 2025 -58.29 Mn
Sep 30, 2025 -43.39 Mn
Jun 30, 2025 -12.30 Mn
Mar 31, 2025 -6.27 Mn
Dec 31, 2024 -22.32 Mn
Sep 30, 2024 -13.67 Mn
Jun 30, 2024 -23.20 Mn
Mar 31, 2024 74.10 Mn
Dec 31, 2023 -26.80 Mn
Sep 30, 2023 -24.18 Mn
Jun 30, 2023 -20.03 Mn
Mar 31, 2023 -17.79 Mn
Dec 31, 2022 -57.49 Mn
Sep 30, 2022 72.80 Mn
Jun 30, 2022 -151.43 Mn
Mar 31, 2022 -28.10 Mn
Dec 31, 2021 193.58 Mn
Sep 30, 2021 -185.83 Mn
Jun 30, 2021 -68.19 Mn